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Abstract. 
 
In 
 
Caenorhabditis elegans
 
, mutations in the 
 
lin-2
 
 gene inactivate the LET-23 receptor tyrosine ki-
nase/Ras/MAP kinase pathway required for vulval cell 
differentiation. One function of LIN-2 is to localize 
LET-23 to the basal membrane domain of vulval pre-
cursor cells. LIN-2 belongs to the membrane-associated 
guanylate kinase family of proteins. We have cloned 
and characterized the human homolog of LIN-2, 
termed hCASK, and Northern and Western blot analy-
ses reveal that it is ubiquitously expressed. Indirect im-
munofluorescence localizes CASK to distinct lateral 
and/or basal plasma membrane domains in different 
epithelial cell types. We detect in a yeast two-hybrid 
screen that the PDZ domain of hCASK binds to the 
heparan sulfate proteoglycan syndecan-2. This interac-
tion is confirmed using in vitro binding assays and im-
munofluorescent colocalization. Furthermore, we dem-
onstrate that hCASK binds the actin-binding protein 
4.1. Syndecans are known to bind extracellular matrix, 
and to form coreceptor complexes with receptor ty-
rosine kinases. We speculate that CASK mediates a 
link between the extracellular matrix and the actin cy-
toskeleton via its interaction with syndecan and with 
protein 4.1. Like other membrane-associated guanylate 
kinases, its multidomain structure enables it to act as a 
scaffold at the membrane, potentially recruiting multi-
ple proteins and coordinating signal transduction.
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T
 
he
 
 cortical actin cytoskeleton is implicated in orga-
nizing specialized membrane domains and in coor-
dinating membrane-signaling networks. Members
of the membrane-associated guanylate kinase (MAGUK)
 
1
 
family have recently been recognized as important orga-
nizing proteins in these cortical networks (reviewed in
Fanning et al., 1996). MAGUKs are defined by a tripartite
domain structure: a Src homology 3 (SH3) domain, a do-
main with homology to the enzyme guanylate kinase
(GUK), and a PDZ domain. The latter domain is named
for three MAGUK proteins: PSD-95, a 95-kD protein of
the postsynaptic density; Dlg, the product of the 
 
Drosoph-
ila
 
 
 
lethal(1)discs-large-1
 
 tumor suppressor gene; and ZO-1,
a vertebrate tight junction protein (Cho et al., 1992;
Woods and Bryant, 1991; Willott et al., 1993).
Based on their multidomain structure and their specific
membrane localization, MAGUKs are thought to act as
scaffolds, organizing and coupling diverse extracellular
signals at the plasma membrane to intracellular signal
transduction pathways and the cortical cytoskeleton. For
example, in neurons, the related proteins PSD-95 and
hDlg, the human homolog of 
 
Drosophila
 
 Dlg, have been
shown to bind via their PDZ domains to Shaker-type K
 
1
 
channels and NMDA receptors (Kim et al., 1995; Kornau
et al., 1995). They also interact with multiple intracellular
proteins, some involved in signal transduction such as ni-
tric oxide synthase (Brenman et al., 1996
 
a
 
; Brenman et al.,
1996
 
b
 
) and the APC tumor suppressor (Matsumine et al.,
1996). MAGUK proteins associate with the cortical actin
cytoskeleton in different ways. For example, in erythro-
cytes, MAGUK protein p55 is part of a ternary complex
linking the membrane protein glycophorin C to the spec-
trin/actin cytoskeleton via protein 4.1 (Marfatia et al.,
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1997; Marfatia et al., 1994), and in epithelial cells hDlg
also binds protein 4.1 (Lue et al., 1994). The tight junction
MAGUK ZO-1 binds to serine–threonine kinase ZAK
(Balda et al., 1996), and links the transmembrane protein
occludin to the cortical cytoskeleton by binding directly to
f actin (Itoh et al., 1997). In epithelial cells, the 
 
C. elegans
 
protein LIN-2 may share this functional paradigm, and is
known to be required for activity of a receptor tyrosine ki-
nase/Ras/MAP kinase signaling pathway (Hoskins et al.,
1995). However, protein interactions of LIN-2 that under-
lie its potential role as a multidomain scaffolding protein
have yet to be elucidated.
Like all MAGUKs, LIN-2 contains a PDZ, SH3, and a
GUK domain. In addition, at its NH
 
2
 
 terminus, LIN-2 has
a domain with homology to calcium/calmodulin-depen-
dent protein kinase (CAMK; Hoskins et al., 1995). In 
 
C.
elegans
 
, the 
 
lin-2
 
 gene is required for development of the
vulva, the egg-laying orifice on the ventral surface of her-
maphrodites (Ferguson and Horvitz, 1985). Genetic stud-
ies indicate that LIN-2
 
 
 
is responsible for localizing the
LET-23 receptor tyrosine kinase (Aroian et al., 1990) to
the basal domain of vulval precursor cells (Simske et al.,
1996). Receptor mislocalization results in failure of Ras
signal transduction, lack of cell differentiation, and subse-
quent vulvaless phenotype. These studies suggest either
the receptor must be polarized in order to receive the acti-
vating ligand, or that LIN-2 may be involved in organizing
signaling events downstream of the receptor. Presently,
the role of LIN-2 in this pathway is not fully defined; how-
ever, it is known that LIN-2 does not bind directly to the
LET-23 receptor (Simske et al., 1996). Recently, the rat
homolog of LIN-2, termed CASK, was cloned by virtue of
its ability to bind neurexins (Hata et al., 1996), a family of
neuronal transmembrane proteins that localize near syn-
apses and are thought to play a role in axon guidance or
adhesion (Puschel and Betz, 1995). A 
 
Drosophila
 
 homolog
of LIN-2, CAMGUK, has also been reported, but its func-
tion and mutant phenotype are as of yet undefined (Dimi-
tratos et al., 1997).
To explore the structural and signaling role of CASK in
vertebrate epithelial tissues, we have cloned the human
homolog of CASK/LIN-2 (hCASK), and we show in a
yeast two-hybrid screen that the PDZ domain of hCASK
binds to the transmembrane protein syndecan-2. In vitro
binding assays and immunofluorescent colocalization in
multiple tissues confirm this interaction and suggest that
hCASK is capable of binding to all four syndecan family
members (syndecan-1,-2,-3, and -4). Syndecans are cell
surface heparan sulfate proteoglycans that are thought to
act both as extracellular matrix receptors (e.g., through
binding fibronectin, laminin, and collagen types I, III, and
V) and as low-affinity coreceptors with receptor tyrosine
kinases such as bFGFR (reviewed in Carey, 1997). We
demonstrate that in addition to binding syndecan, hCASK
interacts with the actin/spectrin-binding protein 4.1. We
propose that hCASK mediates a link between the extra-
cellular matrix and the cortical actin cytoskeleton. These
results are consistent with the present model of MAGUKs
as scaffolding proteins that recruit or organize other pro-
teins at the plasma membrane to coordinate signal trans-
duction pathways within the cortical cytoskeleton.
 
Materials and Methods
 
Cloning
 
A degenerate PCR strategy was used to amplify hCASK from a fetal lung
cDNA library (CLONTECH Laboratories, Inc., Palo Alto, CA). The
primers were made from the known p55 sequence; the sense primer corre-
sponded to a sequence at the start of the PDZ domain, and the antisense
primer corresponded to a region at the end of the SH3 domain. A 300-bp
PCR product was isolated, subcloned into the vector pCRII (Invitrogen
Corp., Carlsbad, CA), and sequenced. Internal forward and reverse PCR
primers were then designed to its SH3 domain; each one was paired with a
corresponding anchored primer to either the Sp6 or the T7 promoter re-
gions of the vector. Two distinct overlapping PCR products were isolated,
subcloned into the vector pCRII (Invitrogen Corp.), and sequenced. The
first clone encompassed the calmodulin-binding domain and the SH3 do-
main. The second clone extended from the SH3 domain to the end of the
guanylate kinase domain. These two clones were used as probes to screen
an oligo dT–primed human fetal brain cDNA library constructed in
lambda gt10 (Stratagene, La Jolla, CA), and a human liver library in
lambda ZAP specifically primed with anti-sense ZO-1 oligonucleotides
(CLONTECH Laboratories, Inc.). Clones encoding the 5
 
9
 
-most sequence
were obtained by screening an oligo dT- primed human fetal brain cDNA
library in lambda uni-ZAP (Stratagene) with a probe constructed by PCR
amplification of residues 104–289 using a clone from the initial brain
screen as a template. Hybridization probes were coupled to horseradish
peroxidase and detected on x-ray film by a light emission–based system
(Amersham Corp., Arlington Heights, IL). The hCASK cDNA sequence,
Genbank accession no. AF032119, was determined by dideoxy sequencing
of overlapping clones in both directions.
 
Northern Analysis
 
Northern blot derived from multiple human tissues containing 2 
 
m
 
g of
poly(A)
 
1
 
 RNA per lane was obtained from Clontech. The blot was
probed with a 1.073-kb cDNA fragment of hCASK (bases 777–1850) that
was labeled by random priming as per manufacturer’s instructions (Boeh-
ringer Mannheim Corp., Indianapolis, IN) using [
 
a
 
-
 
32
 
P] dCTP (Amer-
sham Corp.). As a control, the same blot was washed and reprobed with a
cDNA fragment of rat 
 
b 
 
actin (kindly provided by Dr. Prabhat Gosh, Yale
University Department of Neurosurgery).
 
Antibodies
 
hCASK antibodies were raised in three rabbits to a recombinant glu-
tathione-S-transferase (GST) fusion protein. The hCASK-GST vector was
constructed by PCR using forward and reverse primers flanking residues
316–415 with an hCASK cDNA plasmid as template. The resulting PCR
product, confirmed by dideoxy sequencing in both directions, was cloned
into the vector pGEX-2T (Promega Corp.). The GST fusion protein was
expressed in 
 
E. coli, 
 
and was purified on glutathione-Sepharose beads
(Pharmacia Biotech, Inc., Piscataway, NJ). The rabbit serum with the
highest titer was used for all data shown here. Antibodies are affinity-
purified using antigen immobilized on a CNBr-activated Sepharose col-
umn (Pharmacia Biotech, Inc.). Rat anti-mouse syndecan-1 and synde-
can-2 antibodies, 281-2 and F-90, respectively, were the generous gift of
Dr. Merton Bernfield (Children’s Hospital, Harvard Medical School).
 
Western Analysis
 
Rat tissue samples were prepared using dounce homogenization in 1 mM
NaHCO
 
3
 
 in the presence of protease inhibitors, followed by addition of an
SDS-based gel sample buffer (Fallon et al., 1993). Equal total protein
amounts were loaded in each well (BCA Protein Assay; Pierce Chemical
Co., Rockford, IL), and samples were resolved by SDS-PAGE on 10%
acrylamide gels (Laemmli, 1970). Proteins were transferred to nitrocellu-
lose (Towbin et al., 1979), and nonspecific binding was blocked with 10%
nonfat dry milk in PBS for at least 1 h. Blots were probed with affinity-
purified rabbit anti-hCASK antibodies, and detection was by enhanced
chemiluminescence (Amersham Corp.).
 
Immunofluorescence
 
Tissue was harvested, fixed in 4% paraformaldehyde, and 5-
 
m
 
m serial sec- 
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tions were cut by conventional methods (Yale Critical Technologies Cen-
ter). Paraffin was removed from sections by incubating 2 
 
3 
 
5 min in xy-
lene, followed by 3 
 
3 
 
3 min in 100% ethanol. Endogenous peroxidase
activity was blocked by incubating in methanol/hydrogen peroxide for 30
min. Sections were rinsed in TBS, and then hydrated (dH
 
2
 
O) for at least 5
min. Antigenicity was retrieved in a pressure cooker filled with dilute cit-
ric acid buffer (3.84 g Na citrate in 2 L dH
 
2
 
O, pH 6.0), as described in
Norton et al. (1994). Sections were rinsed again in TBS and blocked for 1 h
at room temperature in 10% goat serum. The sections were labeled with
affinity-purified rabbit anti-hCASK or rat antisyndecan (281-2 or F-90)
primary antibodies overnight at 4
 
8
 
C. Slides were washed 5
 
3
 
 in TBS, 1
 
3
 
 in
0.01% Triton/TBS, and 1
 
3
 
 in TBS. Texas Red or FITC-conjugated anti-
rabbit or Texas-Red anti-rat secondary antibodies (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA) were added for 1 h at room
temperature. Subsequently, sections were washed as described above and
mounted with Vectashield™ (Vector Labs, Inc., Burlingame, CA). Label-
ing was visualized using a Microphot™ (Nikon, Inc., Melville, NY) with
20
 
3
 
 and 40
 
3
 
 objectives and images captured using either T-MAX 400
film or a Sensys cooled-CCD camera (Photometric, Tucson, AZ) and pro-
cessed using Adobe Photoshop 3.0 or Image Pro Plus (Media Cybernetics,
Silver Spring, MD), respectively.
 
Yeast Two-Hybrid
 
The yeast two-hybrid screen was performed in the laboratory of Dr. Mor-
gan Sheng (Massachusetts General Hospital, Harvard Medical School).
Yeast two-hybrid screens were done using the L40 yeast strain as de-
scribed in Niethammer et al. (1996). The bait consisted of the PDZ do-
main of hCASK (residues 489–572) made by PCR using specific primers
and subcloned in frame with the lexA DNA-binding domain into vector
pBHA. The bait was used to screen a human liver cDNA library con-
structed in pGAD10 (Clontech). DNA from positive interacting clones, as
assayed by beta-galactosidase staining, was isolated from yeast colonies
and transformed into HB101 bacteria by electroporation, isolated from
bacteria, and sequenced.
 
Peptide-binding Assay
 
A hCASK PDZ-GST recombinant fusion protein was made by PCR am-
plification of the PDZ domain (residues 489–572) using hCASK cDNA as
a template. The resulting PCR product was sequenced and subcloned into
pGEX-2T vector (Promega Corp., Madison, WI). The fusion protein was
expressed in 
 
Escherichia coli
 
 and purified on glutathione-Sepharose beads
(Sigma Chemical Co., St. Louis, MO). A COOH-terminal syndecan-2
peptide (APTKEFYA-COOH) was synthesized and coupled to CNBr-
activated Sepharose beads (Pharmacia). The beads with immobilized pep-
tide were then incubated with recombinant GST-hCASK PDZ fusion pro-
tein (4 
 
m
 
g/ml) with various concentrations (0–200 
 
m
 
M) of the same synde-
can-2 peptide or with homologous syndecan-1 (TKQEEFYA-COOH)
peptide in TBS buffer containing 0.01% NP-40, BSA (1 mg/ml) and DTT
(1 mM; as described in Songyang et al., 1996). Controls consisted of GST
alone incubated with beads containing immobilized peptide, GST-hCASK
PDZ fusion protein with uncoupled beads, and GST-PDZ fusion protein
incubated with a mixture of beads coupled to syn-2 peptide and an excess
of control dlg peptides in solution. The dlg control peptide
(KKKKETDV-COOH) has optimal binding affinity for murine Dlg PDZ
as determined by Songyang et al. (1996) using an oriented peptide library
technique. All mixtures were incubated at 4
 
8
 
C for 45 min. Bound proteins
were washed three times with TBS buffer, separated by SDS-PAGE,
transferred to nitrocellulose, and visualized by protein immunoblotting
with anti-GST antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).
Relative binding was quantified using a Gel-Pro scanner (Media Cyber-
netics, MD).
 
Protein 4.1 Blot Overlay
and Sedimentation-binding Assay
 
Preparation of 
 
125
 
I-labeled NH
 
2
 
-terminal 30-kD domain of protein 4.1 and
subsequent blot overlay and sedimentation-binding assays were per-
formed as described in Marfatia et al. (1995). The hCASK GST fusion
protein used in these assays contains most of the MAGUK region of
hCASK, extending from residue 536 through the COOH terminus. This
construct was made by subcloning a restriction enzyme DNA fragment of
hCASK into the pGEX-2T vector (Promega Corp., Madison, WI). The
GST-p55 construct used as a positive control in these experiments con-
tains the full-length human p55 sequence, and has been described previ-
ously in Marfatia et al. (1994). Recombinant fusion proteins were ex-
pressed in 
 
E. coli
 
 and purified on glutathione-Sepharose beads (Sigma
Chemical Co.).
 
Results
 
Cloning of Human CASK/Lin-2 and 
Initial Characterization
 
In 
 
C. elegans
 
, LIN-2 is required to localize the LET-23 re-
ceptor tyrosine kinase to the basal membrane where it can
respond to the LIN-3/EGF-like ligand and induce a Ras/
MAP kinase signaling pathway required for cell fate deter-
mination (Simske, 1996). The original goal of our work
was to determine whether there was a functional verte-
brate homolog of
 
 
 
LIN-2. A degenerate PCR strategy fol-
lowed by hybridization library screening was used to clone
the full-length hCASK/LIN-2 (hCASK) cDNA from hu-
man liver, lung, and brain libraries (Materials and Meth-
ods). Sequence analysis of hCASK cDNA confirms that it
is composed of an NH
 
2
 
-terminal calcium calmodulin-
dependent protein kinase–like domain, PDZ and SH3 do-
mains, a potential protein 4.1 binding motif, and a domain
homologous to guanylate kinase. The high degree of over-
all identity with rat CASK and 
 
C. elegans
 
 LIN-2, 99% and
52% respectively, implies that this gene represents the hu-
man ortholog (Fig. 1). We note that the protein sequence
of hCASK that lies C-terminal to the CAMK domain (i.e.,
the MAGUK region) is more similar to the erythrocyte
protein p55 than to other MAGUK proteins.
Northern analysis of human tissue poly(A)
 
1
 
 RNA dem-
onstrates that hCASK is ubiquitously expressed (Fig. 2).
All tissues examined have a 4.4-kb mRNA transcript,
which is especially enriched in pancreas, brain, and heart
relative to a 
 
b
 
-actin mRNA loading control. Some tissues
(heart, brain, muscle and pancreas) have a conspicuous
8.5-kb transcript. Others (particularly placenta and kid-
ney) express a transcript of 3.1 kb. All three transcript
sizes are large enough to encompass the full-length coding
region (2765 bp).
Figure 1. Comparative domain organization of hCASK-related
proteins. Sequence homology of hCASK with rat CASK (Hata
et al., 1996), C. elegans LIN-2 (Hoskins et al., 1995), human
erythrocyte p55 (Ruff et al., 1991), and alpha subunit of rat brain
CAMKII (Lin et al., 1987). hCASK protein contains a domain
homologous to CAMKII, a conserved calmodulin-binding do-
main (CBD), a PDZ domain, an SH3 domain, a potential protein
4.1–binding motif (4.1), and a domain homologous to guanylate
kinase (GUK). Percent amino acid identities within defined do-
mains are noted in comparison with hCASK. 
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Western blot analysis reveals a predominant band of
CASK reactivity at 
 
z
 
112 kD in all rat and human tissues
and cultured cells tested (Fig. 3). This size is consistent
with the full-length coding region, with the 110-kD nema-
tode protein (Hoskins et al., 1995), and with the previously
reported 112-kD rat protein (Hata et al., 1996). Antibod-
ies for these studies were raised in rabbits against a recom-
binant GST fusion protein that included 94 residues
COOH-terminal to the putative calmodulin-binding do-
main of hCASK, an area that corresponds to the highly
variable association domain of CAM kinases. The de-
duced amino acid sequence of 921 residues predicts a pro-
tein of 106 kD, which is 5% smaller than the apparent mo-
lecular mass demonstrated by SDS/PAGE. A minor band
of 75 kD was sometimes detected by antibodies affinity-
purified against GST-CASK. Immunoreactivity towards
this 75-kD species could be selectively reduced by immuno-
depletion of anti-GST activity from the affinity-purified
anti-CASK sera.
 
CASK Localizes to Specific Membrane Domains in 
Different Epithelial Cell Types
 
Localization of 
 
C. elegans
 
 LIN-2 has not been determined;
however, indirect evidence implies that it is localized to
the basal domain of prevulval epithelial cells (Simske et al.,
1996). To determine whether CASK also shows specific
membrane domain localization, we performed indirect im-
munofluorescence microscopy on paraffin-embedded rat
tissue sections using affinity-purified anti-hCASK anti-
bodies. CASK was observed to localize to specific but dif-
ferent membrane domains in different epithelial cell types.
For example, in choroid plexus epithelial cells and in hepa-
tocytes, CASK is predominantly at the basal surface (Fig.
4 
 
a
 
 and Fig. 6 
 
a
 
). In contrast, in small and large intestinal
epithelial cells, the staining is concentrated in the basal re-
gion of the lateral plasma membrane (Fig. 4 
 
b 
 
and
 
 
 
Fig.
 
 
 
6 
 
c
 
).
In pancreatic acinar cells and in renal distal tubule cells
(not shown), staining is localized equally along the basal
and lateral membranes (Fig. 6 
 
e
 
). CASK was never ob-
served at the apical membrane of any cell type tested.
Specificity for CASK was demonstrated by the ability of
immobilized GST–CASK fusion protein to deplete the an-
tiserum of all anti-CASK reactivity, and to abolish the ob-
served cell immunostaining. Analogous immunodepletion
of the antiserum with immobilized GST had no effect on
the observed immunolocalization of CASK (data not
shown).
 
The PDZ Domain of hCASK Binds to the COOH 
Terminus of Syndecans
 
The restricted subcellular localization of CASK is similar
to that of other PDZ-containing proteins, some of which
have been shown to bind to COOH termini of transmem-
brane proteins in a sequence-specific fashion (reviewed in
Fanning and Anderson, 1996). In neurons, rat CASK has
been shown to bind to the COOH terminus of the neuron-
specific cell surface protein neurexin; this binding is pre-
sumed but not proven to require the CASK PDZ domain
(Hata et al., 1996). To identify a binding partner for
hCASK in polarized epithelial cells, we performed a yeast
two-hybrid screen of a human liver cDNA library using
the PDZ domain of hCASK as bait. One positive inter-
Figure 2. hCASK is ubiquitously expressed. Northern blot of hu-
man poly(A)1 mRNA probed with hCASK cDNA. The tissue
source of the blotted RNA is indicated above each lane. Three
differently sized transcripts are apparent at 8.5 kb, 4.4 kb, and 3.1
kb. All are large enough to encode full-length cDNA (2.765 kb).
The position of size markers are indicated on the left (kb). Hy-
bridization to 1.9-kb b-actin transcript is shown in the bottom
panel as a loading control. Heart and skeletal muscle characteris-
tically show a second b-actin mRNA form at 1.5 kb.
Figure 3. Anti-hCASK antibodies recognize one band at 112 kD,
consistent with full-length cDNA and the nematode homolog.
Immunoblot of rat tissues probed with affinity-purified anti-
hCASK antibodies. Whole tissue samples were normalized by to-
tal protein, and were resolved by SDS-PAGE (10%). Positions of
molecular weight markers are shown. 
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acting clone was isolated, which encoded residue 107
through the cytoplasmic COOH terminus (residue 201) of
the cell surface heparan sulfate proteoglycan syndecan-2
(Marynen et al., 1989).
To verify the yeast two-hybrid result and to test whether
it is based on a typical PDZ domain tail interaction requir-
ing binding to the COOH terminus of the target protein,
we performed in vitro binding studies with a syndecan-2
peptide and a GST-hCASK PDZ fusion protein. A synde-
can peptide representing the last eight residues (Fig. 5 
 
a
 
)
was coupled to CNBr-activated Sepharose beads. The
beads with immobilized peptide were then incubated with
hCASK recombinant GST-PDZ fusion protein in the
presence of various concentrations of soluble peptide (Fig.
5 
 
b
 
). hCASK bound specifically to the syndecan-2 peptide
based on several criteria. First, GST alone did not bind to
beads containing immobilized peptide. Second, GST-PDZ
fusion protein did not bind to uncoupled beads. Third,
binding of GST-PDZ fusion protein to immobilized syn-
decan-2 was successfully competed off with increasing
amounts of soluble peptide. 50% maximal displacement of
hCASK PDZ domain occurred at a range of 40–70 
 
m
 
M
peptide, an apparent inhibition constant consistent with
other biologically relevant PDZ domain interactions
(Songyang et al., 1997). Binding was not affected by the
presence of a control peptide representing a sequence that
has optimal binding affinity for the murine Dlg PDZ do-
main, as previously determined by the oriented peptide li-
brary technique (Songyang et al., 1997).
To investigate whether hCASK is capable of binding to
syndecan-1 (Saunders et al., 1989; Mali et al., 1990), the
GST-hCASK PDZ fusion protein was incubated with in-
creasing amounts of a soluble peptide representing the last
eight amino acids of syndecan-1, and the syndecan-2 pep-
tide coupled to beads. Identical competition characteris-
tics were observed for the syndecan-1 peptide as for the
syndecan-2 peptide (Fig. 5 
 
b
 
). These experiments suggest
that the last four residues (EFYA) shared by syndecans 1
and 2 are sufficient for hCASK PDZ binding. Further-
more, because all four syndecan gene products end in the
same last four residues, we predict that hCASK has the
ability to bind to syndecans 3 (Carey et al., 1992) and 4
(Kojima et al., 1992) as well (Fig. 5 
 
a
 
).
 
CASK and Syndecan Colocalize In Situ in 
Epithelial Tissues
 
Yeast two-hybrid results and peptide-binding studies re-
veal that hCASK is capable of binding to syndecans 1 and
2. To determine whether they colocalize in vivo, indirect
immunofluoresence microscopy was performed on rat tis-
sues using anti-hCASK, anti-syndecan-1, and anti-synde-
can-2 antibodies (Materials and Methods). CASK, synde-
can-1, and syndecan-2 (not shown) colocalize to the basal
sinusoidal surface of hepatocytes in liver (Fig. 6, 
 
a
 
 and 
 
b
 
).
In contrast, in small intestine where syndecan-1 expression
predominates over the other syndecan proteins, both
CASK and syndecan-1 decorate the lateral membrane of
enterocytes with a striking and similar concentration of
staining in the most basal aspect of the lateral membrane.
However, in the lamina propria, an area rich in blood ves-
sels and lymphatics, syndecan appears to stain all vessels,
whereas CASK is less conspicuous or absent (Fig. 6, 
 
c
 
 and
 
d
 
). In pancreas, CASK and syndecan-1 are located with
similar levels on both the basal and lateral membranes of
acinar cells (Fig. 6, 
 
e
 
 and 
 
f
 
). Furthermore, they both local-
ize only to the lateral membrane of cells lining pancreatic
ducts (not shown).
The in vivo
 
 
 
interaction between CASK and syndecan is
strongly supported by their peculiar pattern of colocaliza-
Figure 4. CASK localizes to distinct membrane domains in dif-
ferent epithelial cell types. Rat tissue sections were stained with
affinity-purified anti-hCASK antibodies. (a) In choroid plexus
epithelial cells, CASK localizes along the basal membrane; bar,
100 mm. (b) In colonic epithelial cells, CASK is enriched at the
base of the lateral plasma membrane; bar, 40 mm. Figure 5. The PDZ domain of hCASK binds to the COOH-ter-
minal sequence of syndecans. (a) Alignment of the cytoplasmic
domains of rat syndecan family members demonstrate the high
degree of homology among the four proteins (reviewed in Bern-
field et al., 1992). In particular, note the conservation of the last
four residues (in bold), which in other proteins are known to de-
termine PDZ tail-binding specificity. (b) Direct binding study
with syn-2 peptide and hCASK PDZ fusion protein. Syn-2 pep-
tide representing the last eight residues was coupled to CNBr-
activated Sepharose beads. The beads with immobilized peptide
were incubated with GST-PDZ recombinant fusion protein with
increasing concentrations of syn-2 or syn-1 peptides (0–200 mM)
in solution. Controls consisted of GST alone incubated with pep-
tides immobilized on beads; GST-PDZ fusion protein with pep-
tide-free Sepharose beads (Beads alone); and GST-PDZ fusion
protein incubated with beads coupled to syn-2 peptide and 50 mM
control dlg peptide in solution (Ctr). The dlg control peptide
(KKKKETDV-COOH) has optimal binding affinity for murine
Dlg PDZ domain (Songyang et al., 1997). 
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tion on the lateral, basal, or basolateral membrane domain
depending on the epithelial cell type. Despite evidence for
colocalization and specific in vitro binding, we were un-
able to coimmunoprecipitate a CASK–syndecan complex
from detergent-solubilized cells. This result is consistent
with results reported for CASK–neurexin and for other
PDZ domain–transmembrane protein interactions in which
binding had been established by other methods (Hata et
al., 1996; Niethammer et al., 1996). A possible explanation
for the inability to coimmunoprecipitate transmembrane
proteins and their PDZ-containing binding partners may
be that conditions necessary for extracting both proteins
do not maintain the interaction.
 
hCASK Binds to the Actin/Spectrin-Binding Protein 4.1
 
MAGUK proteins p55 and hDlg have been shown to bind
the actin-binding protein 4.1 through a conserved lysine-
rich sequence motif located between the SH3 and the
GUK domains (Marfatia et al., 1995; Lue et al., 1994). Se-
quence comparisons reveal that hCASK shares striking
homology with p55 and hDlg in this putative 4.1 binding
region. The reciprocal binding site on protein 4.1 for p55
resides within a 30-kD domain produced by chymotrypsin
digestion of native protein 4.1 (Marfatia et al., 1994). To
determine whether hCASK can bind to protein 4.1, we
performed in vitro binding assays similar to those used to
establish the interaction between the NH
 
2
 
-terminal 30-kD
domain of erythrocyte protein 4.1, and both p55 and hDlg
(Marfatia et al., 1994; Lue et al., 1994).
In a blot overlay assay, a 
 
125I-labeled 30-kD fragment of
protein 4.1 was incubated with fusion proteins GST-
hCASK, GST-p55, and GST alone immobilized on nitro-
cellulose (Fig. 7 a). GST–hCASK encodes a fragment of
hCASK from the middle of the PDZ domain through the
COOH terminus, and includes the putative protein 4.1
binding motif. The radiolabeled protein 4.1 fragment
bound to GST-hCASK and to GST-p55, but not to GST
alone. In addition, radiolabeled protein 4.1 bound to a dif-
ferent recombinant GST-hCASK fusion protein that also
contains the putative 4.1 binding site (data not shown).
The interaction of hCASK with protein 4.1 was further
investigated by incubating a 125I-labeled 30-kD fragment
of protein 4.1 with glutathione–Sepharose beads bound to
the fusion protein GST-hCASK or to GST alone (Fig. 7
b). Significantly more radiolabeled protein 4.1 bound to
GST-hCASK than to GST alone, and the binding was ef-
fectively competed by incubation in the presence of a 103
molar excess of nonradiolabeled protein 4.1.
Discussion
Our studies extend the genetic description of C. elegans
LIN-2 to its potential role in vertebrate epithelial cells,
and provide several new insights about its possible func-
tion. We demonstrate that CASK is ubiquitously ex-
pressed and is localized predominantly to either the basal,
lateral or basolateral plasma membrane domains in differ-
ent epithelial cell types. In addition, we show that hCASK
binds to the heparan sulfate proteoglycan syndecan-2 via
its PDZ domain, and to the actin/spectrin-binding protein
4.1, presumably through a previously characterized motif
located between the SH3 and GUK domains (Marfatia
et al., 1995; Lue et al., 1994). Based on these associations,
we speculate that in epithelial cells CASK mediates a di-
rect link between the extracellular matrix and the cortical
actin cytoskeleton through syndecan and protein 4.1, re-
spectively (Fig. 8). These interactions may have functional
significance for membrane signaling and assembly of cell
polarity.
Human CASK demonstrates a high degree of overall
identity with rat CASK, Drosophila CAMGUK, and C. el-
egans LIN-2. It is composed of an NH2-terminal CAMK, a
PDZ domain, an SH3 domain, a protein 4.1-binding motif,
and a domain homologous to GUK. Sequence alignments
with the alpha subunit of rat brain CAMKII (Lin et al.,
Figure 6. CASK and syndecan-1 colocalize in situ in epithelial
tissues. Mouse tissue sections were stained with affinity-purified
rabbit anti-hCASK and monoclonal rat anti-syndecan-1 antibod-
ies and visualized with Texas red–conjugated anti-rabbit and
FITC-conjugated anti-rat secondary antibodies, respectively. (a,
b) In hepatocytes, both CASK and syndecan-1 are located along
the basal sinusoidal membrane. (c, d) In small intestinal entero-
cytes, the two proteins are localized at the lateral plasma mem-
brane. CASK also stains a subset of the vessels that syndecan-1
stains in the lamina propria. (e, f) In the pancreas, CASK and
syndecan-1 colocalize on both the basal and lateral membrane
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1987) suggest that hCASK is likely to bind calmodulin, but
is unlikely to be an active enzyme. The latter conclusion is
based on substitution within hCASK of several residues
that are conserved among all enzymatically active CAMKs,
including two within the putative ATP binding site (Col-
bran and Soderling, 1990; Hanks et al., 1988). Hata et al.
(1996) have shown that recombinant fragments of CASK
containing its putative calmodulin-binding site bind calmod-
ulin efficiently in a calcium-dependent manner. However,
they found no evidence for CAMK activity using recombi-
nant proteins, and did not observe autophosphorylation of
CAMK domains expressed in bacteria, mammalian cells,
or insect cells (Hata et al., 1996). In native CAMKII, calmod-
ulin  binding releases autoinhibition on the catalytic do-
main (reviewed in Braun and Schulman, 1995). By anal-
ogy, calmodulin binding may regulate CASK by inducing a
conformational change, although in this case it would not
be expected to induce kinase activity.
Sequence comparisons of hCASK with porcine and
yeast GUK enzymes suggest that hCASK has the potential
to be an active guanylate kinase enzyme, although this ac-
tivity has not been tested (Zschocke et al., 1993; Stehle
and Schulz, 1992). p55 is the only other MAGUK that con-
serves or conservatively substitutes all of the residues
known to be essential for GUK enzymatic activity. Active
GUK domains might contribute to signaling by affecting
guanine nucleotide levels and activity of small GTP-bind-
ing proteins, or by possessing effector function themselves
when bound to guanine nucleotides. Recently, a novel
protein family called GKAP (guanylate kinase–associated
protein) or SAPAP (SAP90/PSD-95–associated protein)
has been shown to bind to the GUK domain of PSD-95/
SAP90 and related synaptic proteins (Kim et al., 1997;
Takeuchi et al., 1997), although their sequences are novel
and functions unknown. None of these newly identified
proteins bind the GUK domain of CASK, leaving open
the possibility that additional GKAP/SAPAP-like pro-
teins remain to be discovered.
In this study we demonstrate that CASK is ubiquitously
expressed and shows distinct localization patterns pre-
dominantly at the basal, lateral, or basolateral membrane
domains in different epithelial cell types. CASK appears
to be excluded from the apical membrane compartment.
Despite its apparently distinct localization patterns, CASK
Figure 7. hCASK binds to the actin/spectrin-binding protein 4.1.
(a) [125I]-labeled 30-kD fragment of protein 4.1 was incubated
with GST-hCASK, GST-p55, and GST alone immobilized on ni-
trocellulose. Radiolabeled protein 4.1 bound GST-hCASK and
GST-p55, but not GST alone. (Left) SDS-PAGE of expressed fu-
sion proteins used for the experiment. (b)125I-labeled 30-kD frag-
ment of protein 4.1 was incubated with GST-hCASK and GST
alone coupled to glutathione Sepharose beads. Significantly more
radiolabeled protein 4.1 bound to GST-hCASK than to GST
alone, and the binding was effectively competed by incubation
with an excess of nonradiolabeled protein 4.1. Experiments were
performed in triplicate.
Figure 8. A hypothetical model of hCASK mediating a direct
link between extracellular matrix and actin cytoskeleton by bind-
ing to syndecan and protein 4.1. hCASK binds to syndecan via its
PDZ domain, and to protein 4.1 presumably through a sequence
motif located between the SH3 and the GUK domains, as previ-
ously demonstrated for p55 and hDlg. Syndecans have been
shown to bind extracellular matrix components and to form non-
covalent coreceptor complexes with receptor tyrosine kinases,
such as bFGFR. hCASK, in close proximity to the receptor ty-
rosine kinase, could act on the cytoplasmic surface to recruit pro-
teins used in signaling events downstream of the bFGF receptor,
or alternatively, could itself be a substrate for the receptor.The Journal of Cell Biology, Volume 142, 1998 136
is always associated with a membrane domain that faces
bloodborne growth factors and hormones. This fact sug-
gests a role for CASK analogous to that of C. elegans LIN-2,
which is thought to localize to the basal membrane domain
of vulval precursor epithelial cells in association with the
LET-23 growth factor receptor.
To identify a binding partner for hCASK in polarized
epithelial cells, we performed a yeast two-hybrid screen of
a human liver library using the PDZ domain as bait. We
found that the hCASK PDZ domain binds to the trans-
membrane protein syndecan-2. X-ray crystallography and
mutational analysis had previously demonstrated that the
COOH-terminal residues of the cytoplasmic tail of PDZ-
binding transmembrane proteins confer the specificity of
the PDZ domain-tail interaction (Doyle et al., 1996; Kim
et al., 1995). Using an oriented peptide library technique,
Songyang et al. (1997) assigned PDZ domains into classes
according to their peptide-binding specificities. hCASK,
like p55 and Tiam-1, falls in the so-called class II, selecting
peptides with hydrophobic or aromatic side chains at posi-
tion –2 relative to the carboxy terminus. The physical basis
for this specificity is consistent with the recent x-ray crys-
talographic structure of the hCASK PDZ domain (Daniels
et al., 1998). Inspection of known PDZ-binding motifs re-
veals that E at position –3 is very common (Doyle et al.,
1996). Syndecan-2, which terminates in the sequence
EFYA, as well as neurexin, which ends with residues
EYYV, are both predicted to bind to the PDZ domain of
CASK. It is possible that CASK has other PDZ-binding
partners in addition to syndecan and neurexin, that termi-
nate with hydrophobic or aromatic residues.
In vitro binding studies reported here demonstrate that
the PDZ domain of CASK binds specifically to the COOH-
terminal EFYA motif present in both syndecans 1 and 2.
The apparent Ki in our binding assay with syndecan pep-
tides consisting of the terminal eight residues is in the range
of 40–70 mM, consistent with previously reported PDZ
interactions (Songyang et al., 1996). Although we were un-
able to coimmunoprecipitate a complex of CASK and syn-
decan from native cells, this result has been the experience
for other PDZ interactions for which there is either ge-
netic or functional proof of an interaction.
In addition to these in vitro binding studies, we demon-
strate that CASK and syndecans 1 and 2 share the same
membrane domain–restricted distribution in different epi-
thelial cells. Although we lack antibodies to investigate
a possible colocalization with syndecans 3 and 4, the
COOH-terminal sequence identity among all four synde-
can gene products suggests that CASK can interact with
all syndecans. This possibility is of interest because while
all contain a highly conserved cytoplasmic domain, synde-
cans have divergent extracellular domains, cellular expres-
sion patterns, and presumed functions (Carey, 1997). For
example, syndecan-1, expressed almost exclusively in epi-
thelial cells of mature tissue, is thought to act as a matrix
receptor, regulate cell morphology, and participate in a
coreceptor complex with bFGF receptor. In contrast, syn-
decan-4, expressed by both epithelial and fibroblastic cells,
is enriched and codistributed with integrins in focal con-
tacts, raising the possibility that syndecan-4 forms a co-
receptor complex with integrin receptors (Woods and
Couchman, 1994).
In this study we show that CASK, like p55 and hDlg,
binds to the NH2-terminal 30-kD domain of erythrocyte
protein 4.1. This domain is highly conserved among 4.1-
related proteins, raising the possibility that MAGUK pro-
teins can bind to other 4.1 family members such as ezrin,
radixin, moesin, merlin, or talin. All of these proteins have
been implicated in organizing actin in the cortical cyto-
skeleton (reviewed in Tsukita and Yonemura, 1997). Per-
haps an interaction with MAGUK proteins offers a mech-
anism for tethering transmembrane proteins into the
cortical actin network. This connection would serve to lo-
calize proteins to the proper cell membrane domain and
bring them into proximity with other proteins in the same
signaling pathway. For example, CASK could stabilize
syndecan at the basolateral surface where it binds extra-
cellular matrix and acts as a coreceptor for ligands such as
bFGF. CASK might then recruit other proteins used in
signaling events downstream of the bFGF receptor. Al-
though direct interactions between CASK and signaling
proteins have not yet been demonstrated, other MAGUKs
clearly have such associations. For example, hDlg binds
via its proline-rich NH2-terminal domain to the SH3 do-
main of the nonreceptor tyrosine kinase p56 lck in lym-
phocytes (Hanada et al., 1997). It also binds the tumor
suppressor APC in epithelial cells and neurons (Matsum-
ine et al., 1996). The synaptic proteins PSD-95 and PSD-93
bind neuronal nitric oxide synthase (Brenman et al., 1996a
and Brenman et al., 1996b). Finally, the tight junction
MAGUK ZO-1 binds through its SH3 domain to a novel
serine threonine kinase, ZO-1–associated kinase, or ZAK
(Balda et al., 1996).
The syndecan–CASK–protein 4.1 interaction may ex-
plain the results of previous studies demonstrating a regu-
lated association between syndecan and the actin cytoskel-
eton. In stably transfected Schwann cells, syndecan-1 has
been seen to colocalize transiently with actin filaments
during cell spreading. Similarly, antibody-mediated clus-
tering of syndecan molecules on the cell surface also in-
duces actin colocalization (reviewed in Carey, 1997). Mu-
tational analysis has implicated the involvement of a
tyrosine residue within the syndecan-1 cytoplasmic do-
main in this connection (Carey et al., 1996); however, the
potential role of CASK as a link has not yet been ex-
plored.
Our results suggest several novel roles for CASK in epi-
thelial cells. Activation of the bFGF receptor tyrosine ki-
nase is optimal when the bFGF ligand is presented as a
ternary complex bound to the heparan sulfate moieties of
syndecan (Rapraeger et al., 1991; Yayon et al., 1991). If
CASK is involved in bFGF signaling it may in this context
facilitate receptor tyrosine kinase (RTK) function by re-
stricting syndecan to the basolateral cell membrane with
the receptor. A previously published study supports a role
for CASK in proper syndecan localization (Miettinen et al.,
1994). When wild-type syndecan was transfected into Ma-
din-Darby canine kidney cells, it appeared on the basal
and lateral membrane domains. A truncated syndecan
missing the last twelve amino acids of the cytoplasmic tail
mislocalized to both the apical and basolateral cell sur-
faces. These data may be explained by the inability of
truncated syndecan to bind the PDZ domain of CASK.
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correct membrane domains; alternatively, CASK may be
stabilizing syndecan at the membrane by linking it to the
actin cytoskeleton.
In vertebrate epithelial cells and in nematode vulval
precursor cells, indirect evidence suggests that CASK and
LIN-2, respectively, are each in close proximity to a recep-
tor tyrosine kinase. LIN-2 is responsible for localizing the
LET-23 receptor to the basal cell surface through a mech-
anism that does not involve direct binding to the RTK
(Simske et al., 1996). There is genetic evidence in C. ele-
gans for involvement of other proteins in intracellular
LET-23 binding (Simske et al., 1996). However, by anal-
ogy to the proposed CASK–syndecan–bFGFR interaction
in mammalian cells, it is possible that LIN-2 binds to the
C. elegans syndecan homolog, perhaps forming a corecep-
tor complex with the LET-23 RTK. Interestingly, C. ele-
gans syndecan terminates with the same four residues as
the vertebrate syndecan EFYA (Carey, 1997), suggesting
that the LIN-2 PDZ domain is capable of binding to its
COOH-terminal tail. Whatever the mechanism of associa-
tion between CASK/LIN-2 and the cytoplasmic domain of
RTKs, this proximity raises the possibility of a role in sig-
nal transduction. For example, such a role might be to re-
cruit other signaling molecules, to act itself as a substrate
for the RTK, or to regulate the availability of other sub-
strates. There is presently no direct evidence for this
model; however, CASK/LIN-2 has several domains that
might serve such purposes. These hypotheses provide di-
rections for future experiments concerning the role of
CASK in vertebrate epithelial cell signaling.
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